Provided by Tiger Trade Technology Pte. Ltd.

Zentalis Pharmaceuticals, LLC

3.56
+0.720025.35%
Volume:7.38M
Turnover:26.09M
Market Cap:257.21M
PE:-1.71
High:3.76
Open:3.12
Low:3.06
Close:2.84
52wk High:3.76
52wk Low:1.01
Shares:72.25M
Float Shares:49.98M
Volume Ratio:2.46
T/O Rate:14.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0805
EPS(LYR):-2.3331
ROE:-49.18%
ROA:-24.51%
PB:1.02
PE(LYR):-1.53

Loading ...

Walters Group Reports Acquisition of Common Shares of Zentalis Pharmaceuticals Inc

Reuters
·
Yesterday

BRIEF-Zentalis Pharmaceuticals Provides Corporate Update

Reuters
·
Jan 06

Zentalis Pharmaceuticals Announces Key 2026 Milestones for Azenosertib Development Program

Reuters
·
Jan 06

Zentalis Pharmaceuticals Inc - Denali Part 2a Enrollment Completed; Dose Confirmation Expected 1H 2026

THOMSON REUTERS
·
Jan 06

Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026

THOMSON REUTERS
·
Jan 06

Zentalis Pharmaceuticals Inc - Aspenova Phase 3 Trial Initiation Planned in 1H 2026

THOMSON REUTERS
·
Jan 06

Zentalis Pharmaceuticals Inc - Denali Part 2 Topline Readout Expected by Year End 2026

THOMSON REUTERS
·
Jan 06

Matrix Capital Management Company LP Reports Disposal of Zentalis Pharmaceuticals Common Shares

Reuters
·
Dec 16, 2025

Zentalis Pharmaceuticals Inc - Enters Stock Purchase Agreement With Matrix - SEC Filing

THOMSON REUTERS
·
Dec 16, 2025

Zentalis Pharmaceuticals Director Karan Takhar Resigns

Reuters
·
Dec 16, 2025

Zentalis Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Nov 13, 2025

Zentalis price target lowered to $4 from $8 at Morgan Stanley

TIPRANKS
·
Nov 11, 2025

Wedbush Remains a Hold on Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
Nov 11, 2025

Zentalis Pharmaceuticals (ZNTL) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Nov 11, 2025

Zentalis Pharma Q3 EPS $(0.37) Beats $(0.48) Estimate

Benzinga
·
Nov 11, 2025

Zentalis Pharmaceuticals Q3 net loss narrows

Reuters
·
Nov 11, 2025

Zentalis Pharmaceuticals reports $280.7 million in cash and maintains guidance for DENALI trial topline data by year end 2026

Reuters
·
Nov 11, 2025

BRIEF-Zentalis Pharmaceuticals Q3 EPS USD -0.37

Reuters
·
Nov 11, 2025

Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress

THOMSON REUTERS
·
Nov 11, 2025

Zentalis Pharmaceuticals Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
Nov 08, 2025